Pulmonology · Endobronchial ultrasound

See the airway. Recognize the target.

AI-assisted detection and localization of mucosal abnormalities in endobronchial ultrasound images, supporting differentiation and precision biopsy targeting.

EBUS · AIRWAY REVIEW LIVE AI
Diagnostic accuracy>95%
Analysis modeReal-time · Post-procedural
Clinical fieldEBUS · Pulmonology

01 · Intended use

AI assistance for focused EBUS assessment.

Smart Bronchus supports detection and localization of mucosal abnormalities and relevant node regions in endobronchial ultrasound images.

It brings live and retrospective analysis, precision biopsy targeting and standardized reporting into one interoperable review workflow.

AI
01EBUS acquisitionLive or acquired imaging
02Target intelligenceDetection and differentiation
03Clinical outputTargeting and reporting

The clinical challenge

Subtle findings can create significant uncertainty.

High interobserver variability, suboptimal identification of lesions with malignancy potential and the absence of a standardized method for node recognition can affect staging, treatment selection and workflow efficiency.

“The opportunity is to connect recognition, targeting and reporting in one consistent EBUS workflow.”
02

How it works

From EBUS image to a focused biopsy path.

Information progressively resolves from anatomy recognition to structured clinical output.

01

EBUS image acquisition

Live or previously acquired endobronchial ultrasound images enter the review workflow.

02

Airway and node recognition

Relevant airway anatomy and lymph-node regions are identified for focused assessment.

03

Lesion localization

The AI localizes mucosal abnormalities and highlights regions with bounding-box guidance.

04

Finding differentiation

Image patterns are organized to support differentiation between benign and malignant findings.

05

Targeted clinical review

Structured findings support biopsy targeting, retrospective review and standardized reporting.

AI capabilities

Designed for consistent recognition and precise targeting.

>95%

Diagnostic accuracy

01

Lesion and node detection

Supports earlier and more accurate recognition of relevant lesions and lymph nodes.

02

Finding differentiation

Assists review of image patterns associated with benign and malignant findings.

03

Precision biopsy targeting

Bounding boxes and an aligned biopsy path focus attention on the relevant region.

04

Live and retrospective analysis

Supports real-time use and post-procedural review across compatible devices.

05

Standardized AI reporting

Organizes findings into a consistent output for clinician validation.

Clinical and operational value

Earlier insight. More definitive decisions.

01

Higher accuracy in lesion detection and biopsy targeting

02

Faster and more definitive clinical decisions

03

Lower overall costs through earlier diagnosis and fewer unnecessary procedures

04

Standardized reporting and improved clinical workflow

05

Reduced variability in node recognition and staging support

Smart Bronchus

Bring focused intelligence to every EBUS review.

Talk to our team

The products and technologies showcased are part of our advanced research and development pipeline and may be pending regulatory approval in your market.